Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

INMINM
2 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in INMED PHARMACEUTICALS INC

Yes. Citadel Advisors holds 26,084 shares of INM (Inmed Pharmaceuticals), worth $40,430, as of its Q2 2026 13F filing. It reduced the position by 20,889 shares (-44.5%) from Q1 2026. Citadel Advisors has held INM since Q1 2026, across 2 quarterly 13F filings.

Current Value

$40,430

Current Shares

26,084

Total Value Change

+$10,137

Total Shares Change

-20,889

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
26,084
-44.5%
$40,4300.0%$1.55
0
2026-Q1
New
46,973
-
$30,2930.0%$0.76
30

Other major holders of INM: JANE STREET GROUP, LLC, UBS Group AG, Virtu Financial LLC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used